4D MOLECULAR THERAPEUTICS INC. - COMMON STOCK
25.25
19-四月-24 15:59:58
15 分钟延时
股票
+0.47
+1.90%
今日范围
24.38 - 25.56
ISIN
N/A
来源
NASDAQ
-
28 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
04 3月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
4DMT Reports Full Year 2023 Financial Results and Operational Highlights
29 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
12 2月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
06 2月 2024 23:27:14 条件 Nasdaq GlobeNewswire
-
4D Molecular Therapeutics Announces Proposed Public Offering of Common Stock
05 2月 2024 16:05:00 条件 Nasdaq GlobeNewswire
-
03 2月 2024 17:00:00 条件 Nasdaq GlobeNewswire
-
23 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
4DMT Highlights Recent Clinical Pipeline Progress, Near-Term Milestones and Organizational Updates
04 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
03 1月 2024 08:00:00 条件 Nasdaq GlobeNewswire
-
21 12月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
4DMT to Participate in Upcoming Investor Conferences
15 11月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
4DMT Reports Third Quarter 2023 Financial Results and Operational Highlights
09 11月 2023 16:19:53 条件 Nasdaq GlobeNewswire
-
01 11月 2023 16:00:00 条件 Nasdaq GlobeNewswire
-
30 10月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
25 10月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
23 10月 2023 08:00:00 条件 Nasdaq GlobeNewswire
-
4DMT Appoints Uneek Mehra as Chief Financial and Business Officer
12 9月 2023 16:05:00 条件 Nasdaq GlobeNewswire
- <<
- <
- 1
- >